Skip to Content

Almirall

Therapeutic Focus

Almirall is strongly committed to promoting R&D focused on key therapeutic areas. Our work covers the whole of the drug value chain. A consolidated profitable growth allows us to devote our talent and efforts towards specialty areas and particularly to further grow as a leading dermatology player.

Spasticity in ms

Cancer and its treatment can sometimes cause moderate to severe pain. There are a number of biological reasons why cancer sufferers feel pain, including:

The effects of surgery, radiation treatment and/or chemotherapy

The healing of scars following treatment

The spread of a tumour to other organs, nerves or other parts of the body.

Sativex® (CBD:THC), which was licensed from GW Pharmaceuticals, is already available as a first-in-class treatment for spasticity and associated symptoms caused by multiple sclerosis (MS).